Explore more publications!
American Food & Beverage Online
Got News to Share?

Press Releases

U.S. Superfoods Market Size to Exceed USD 89.64 Billion by 2035, Driven by Functional Foods and Preventive Health Trends
January 7, 2026

U.S. Superfoods Market Size to Exceed USD 89.64 Billion by 2035, Driven by Functional Foods and Preventive Health Trends

Indeterminate GlobeNewswire, Inc.
Vera Therapeutics Announces U.S. FDA Granted Priority Review to Biologics License Application for Atacicept for Treatment of Adults with IgA Nephropathy
January 7, 2026

Vera Therapeutics Announces U.S. FDA Granted Priority Review to Biologics License Application for Atacicept for Treatment of Adults with IgA Nephropathy

Indeterminate GlobeNewswire, Inc.
Palisade Bio Announces Strategic Equity Investment from the Crohn’s & Colitis Foundation’s IBD Ventures Program to Advance PALI-2108
January 7, 2026

Palisade Bio Announces Strategic Equity Investment from the Crohn’s & Colitis Foundation’s IBD Ventures Program to Advance PALI-2108

Indeterminate GlobeNewswire, Inc.
Secretary Naig Congratulates Doug Hoelscher on Appointment as Minister-Counselor to the U.S. Mission to the Food and Agriculture Organization of the United Nations
January 6, 2026

Secretary Naig Congratulates Doug Hoelscher on Appointment as Minister-Counselor to the U.S. Mission to the Food and Agriculture Organization of the United Nations

Gov't Institution Iowa Department of Agriculture and Land Stewardship
Owner: American Government

Iowa Department of Agriculture and Land Stewardship

Gov't Institution
Owned By American Government
Year Founded 1923
Website https://iowaagriculture.gov/
Domain Registration Year Indeterminate
Access Type open
Publication Location United States, Iowa, Des Moines
Owner Country United States

We welcome your feedback!
If you have comments or corrections, let us know.

Ascentage Pharma Announces IND Clearance by the U.S. Food and Drug Administration for BTK Degrader APG-3288
January 7, 2026

Ascentage Pharma Announces IND Clearance by the U.S. Food and Drug Administration for BTK Degrader APG-3288

Indeterminate GlobeNewswire, Inc.
U.S. Next Generation Sequencing Market Intelligence, Revenue Expansion, Key Players and Long-Term Growth Signals
January 6, 2026

U.S. Next Generation Sequencing Market Intelligence, Revenue Expansion, Key Players and Long-Term Growth Signals

Indeterminate GlobeNewswire, Inc.
Abpro and Celltrion, Inc. Announce U.S. FDA IND Clearance for Lead Multispecific Antibody Cancer Candidate ABP-102 / CT-P72
January 6, 2026

Abpro and Celltrion, Inc. Announce U.S. FDA IND Clearance for Lead Multispecific Antibody Cancer Candidate ABP-102 / CT-P72

Indeterminate GlobeNewswire, Inc.
Oculis Announces U.S. FDA Breakthrough Therapy Designation Granted to Privosegtor for Treatment of Optic Neuritis
January 6, 2026

Oculis Announces U.S. FDA Breakthrough Therapy Designation Granted to Privosegtor for Treatment of Optic Neuritis

Indeterminate GlobeNewswire, Inc.
Food Lion Feeds and Boys & Girls Clubs of America Partner to Empower Youth
January 6, 2026

Food Lion Feeds and Boys & Girls Clubs of America Partner to Empower Youth

Indeterminate GlobeNewswire, Inc.
‘Elbows up’ isn’t just for Ontario: Doug Ford’s attacks on Crown Royal threaten more Canadian jobs
January 6, 2026

‘Elbows up’ isn’t just for Ontario: Doug Ford’s attacks on Crown Royal threaten more Canadian jobs

Indeterminate GlobeNewswire, Inc.
Bayou Best Foods Expands Nationwide Availability of Plant-Based Shrimp Through Leading U.S. Foodservice Distributors
January 5, 2026

Bayou Best Foods Expands Nationwide Availability of Plant-Based Shrimp Through Leading U.S. Foodservice Distributors

Neutral EIN Presswire
Where Food Comes From Provides Investors and Media with Video Links to Live Auction of First RaiseWell® Certified Cattle
January 6, 2026

Where Food Comes From Provides Investors and Media with Video Links to Live Auction of First RaiseWell® Certified Cattle

Indeterminate GlobeNewswire, Inc.
Small Molecule API Market Forecast to Reach USD 374.03 Billion by 2035 Driven by Investments and North American Collaborations
January 6, 2026

Small Molecule API Market Forecast to Reach USD 374.03 Billion by 2035 Driven by Investments and North American Collaborations

Indeterminate GlobeNewswire, Inc.
Where Food Comes From, Inc. Announces Launch of RaiseWell® Certified: A New Standard for Natural Livestock Production
January 6, 2026

Where Food Comes From, Inc. Announces Launch of RaiseWell® Certified: A New Standard for Natural Livestock Production

Indeterminate GlobeNewswire, Inc.
CCH Holdings Issues Outlook on Planned Acquisitions, New Business Ventures, Expansion to the U.S. and Africa
January 5, 2026

CCH Holdings Issues Outlook on Planned Acquisitions, New Business Ventures, Expansion to the U.S. and Africa

Indeterminate GlobeNewswire, Inc.
Anavex Life Sciences Receives FDA Feedback on Alzheimer’s Disease Program
January 6, 2026

Anavex Life Sciences Receives FDA Feedback on Alzheimer’s Disease Program

Indeterminate GlobeNewswire, Inc.
Cognition Therapeutics Publishes Phase 2 Clinical Results Showing Zervimesine’s Potential to Slow the Progression of Dementia with Lewy Bodies
January 6, 2026

Cognition Therapeutics Publishes Phase 2 Clinical Results Showing Zervimesine’s Potential to Slow the Progression of Dementia with Lewy Bodies

Indeterminate GlobeNewswire, Inc.
iMDx Prepares for U.S. Commercial Launch of GraftAssureDx as Clinical Trial Nears Completion
January 5, 2026

iMDx Prepares for U.S. Commercial Launch of GraftAssureDx as Clinical Trial Nears Completion

Indeterminate GlobeNewswire, Inc.
Papa Johns and the CHL® Launch “Champions of Tomorrow” to Support Canada’s Young Hockey Players
January 6, 2026

Papa Johns and the CHL® Launch “Champions of Tomorrow” to Support Canada’s Young Hockey Players

Indeterminate GlobeNewswire, Inc.
Rapport Therapeutics Announces Accelerated Initiation of RAP-219 Phase 3 Program, Expansion of Epilepsy Portfolio, and Continued Progress Across the Pipeline
January 7, 2026

Rapport Therapeutics Announces Accelerated Initiation of RAP-219 Phase 3 Program, Expansion of Epilepsy Portfolio, and Continued Progress Across the Pipeline

Indeterminate GlobeNewswire, Inc.
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions